Vanda Pharmaceuticals
VNDA
#8815
Rank
A$0.32 B
Marketcap
A$5.39
Share price
-6.42%
Change (1 day)
-18.20%
Change (1 year)

Earnings for Vanda Pharmaceuticals (VNDA)

Earnings in 2026 (TTM): -A$0.28 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's current earnings are A$0.21 Billion. In 2025 the company made an earning of -A$0.22 Billion a decrease over its 2024 earnings that were of -A$57.8 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vanda Pharmaceuticals from 2005 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.28 Billion26.8%
2025 -A$0.22 Billion271.79%
2024 -A$57.8 Million191.43%
2023 -A$19.84 Million-320.45%
2022 A$8.99 M-84.99%
2021 A$59.93 M54.8%
2020 A$38.71 M19.42%
2019 A$32.42 M4.93%
2018 A$30.89 M-228.6%
2017 -A$24.03 Million-8.98%
2016 -A$26.4 Million-53.79%
2015 -A$57.12 Million-30.18%
2014 -A$81.81 Million173.08%
2013 -A$29.96 Million-25.33%
2012 -A$40.12 Million163.61%
2011 -A$15.22 Million-221.15%
2010 A$12.56 M-124.53%
2009 -A$51.22 Million-29.44%
2008 -A$72.59 Million-36.2%
2007 -A$0.12 Billion21.81%
2006 -A$93.4 Million170.55%
2005 -A$34.53 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$37.25 B-14,215.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$22.06 B-8,459.99%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$9.81 B-3,820.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$47.75 B-18,194.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$10.93 B-4,241.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$16.92 B-6,514.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-A$3.99 Million-98.49%๐Ÿ‡บ๐Ÿ‡ธ USA